Format

Send to

Choose Destination
Ann Intern Med. 2019 May 21;170(10):717-721. doi: 10.7326/M18-2666. Epub 2019 May 7.

Cases in Precision Medicine: Concerns About Privacy and Discrimination After Genomic Sequencing.

Author information

1
Columbia University, New York, New York (D.S.).
2
Columbia University and New York State Psychiatric Institute, New York, New York (P.S.A.).

Abstract

Patients and research participants have indicated that privacy of their genetic test results is an important concern, particularly with respect to insurance coverage. Internists and other physicians whose patients ask about legal protections for information generated by genome sequencing for clinical purposes can provide both reassurance and caution. Protections for medical information in general, as well as laws in some states that provide additional safeguards for genetic data, should reassure patients that this information will remain private. Patients themselves will need to weigh the risks versus the benefits of generating genomic data in deciding whether to undergo exome sequencing.

PMID:
31060048
PMCID:
PMC6715527
[Available on 2020-05-21]
DOI:
10.7326/M18-2666

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center